Detalles de la búsqueda
1.
Suppression of host humoral immunity by Borrelia burgdorferi varies over the course of infection.
Infect Immun
; 92(4): e0001824, 2024 Apr 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-38514468
2.
Oral Immunotherapy With Human Secretory Immunoglobulin A Improves Survival in the Hamster Model of Clostridioides difficile Infection.
J Infect Dis
; 224(8): 1394-1397, 2021 10 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-33588433
3.
Microbiological Characterization of VNRX-5236, a Broad-Spectrum ß-Lactamase Inhibitor for Rescue of the Orally Bioavailable Cephalosporin Ceftibuten as a Carbapenem-Sparing Agent against Strains of Enterobacterales Expressing Extended-Spectrum ß-Lactamases and Serine Carbapenemases.
Antimicrob Agents Chemother
; 65(8): e0055221, 2021 07 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-34001510
4.
Epidemic ribotypes of Clostridium (now Clostridioides) difficile are likely to be more virulent than non-epidemic ribotypes in animal models.
BMC Microbiol
; 20(1): 27, 2020 02 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32024477
5.
Pharmacological, Toxicological, and Dose Range Assessment of OG716, a Novel Lantibiotic for the Treatment of Clostridium difficile-Associated Infection.
Antimicrob Agents Chemother
; 63(4)2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30670434
6.
DAV131A Protects Hamsters from Lethal Clostridioides difficile Infection Induced by Fluoroquinolones.
Antimicrob Agents Chemother
; 64(1)2019 12 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-31636067
7.
Activity of Meropenem-Vaborbactam against Carbapenem-Resistant Enterobacteriaceae in a Murine Model of Pyelonephritis.
Antimicrob Agents Chemother
; 62(1)2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29038270
8.
Antibiotic-Induced Dysbiosis Predicts Mortality in an Animal Model of Clostridium difficile Infection.
Antimicrob Agents Chemother
; 62(10)2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-30061286
9.
Protection of Hamsters from Mortality by Reducing Fecal Moxifloxacin Concentration with DAV131A in a Model of Moxifloxacin-Induced Clostridium difficile Colitis.
Antimicrob Agents Chemother
; 61(10)2017 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-28739791
10.
Can Ceftazidime-Avibactam and Aztreonam Overcome ß-Lactam Resistance Conferred by Metallo-ß-Lactamases in Enterobacteriaceae?
Antimicrob Agents Chemother
; 61(4)2017 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-28167541
11.
Antigen-pulsed bone marrow-derived and pulmonary dendritic cells promote Th2 cell responses and immunopathology in lungs during the pathogenesis of murine Mycoplasma pneumonia.
J Immunol
; 193(3): 1353-63, 2014 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-24973442
12.
In vivo assessment of SMT19969 in a hamster model of clostridium difficile infection.
Antimicrob Agents Chemother
; 58(10): 5714-8, 2014 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-25022586
13.
Perturbation of Staphylococcus aureus gene expression by the enoyl-acyl carrier protein reductase inhibitor AFN-1252.
Antimicrob Agents Chemother
; 57(5): 2182-90, 2013 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-23459481
14.
Small molecule inhibitors of Staphylococcus aureus RnpA alter cellular mRNA turnover, exhibit antimicrobial activity, and attenuate pathogenesis.
PLoS Pathog
; 7(2): e1001287, 2011 Feb 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-21347352
15.
Nasal Tumor Vaccination Protects against Lung Tumor Development by Induction of Resident Effector and Memory Anti-Tumor Immune Responses.
Pharmaceutics
; 15(2)2023 Jan 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-36839766
16.
Surgical Primary Tumor Resection Reduces Accumulation of CD11b+ Myeloid Cells in the Lungs Augmenting the Efficacy of an Intranasal Cancer Vaccination against Secondary Lung Metastasis.
Pharmaceuticals (Basel)
; 17(1)2023 Dec 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-38256885
17.
An mRNA-based platform for the delivery of pathogen-specific IgA into mucosal secretions.
Cell Rep Med
; 4(11): 101253, 2023 11 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-37918405
18.
Design, Synthesis, and Characterization of TNP-2198, a Dual-Targeted Rifamycin-Nitroimidazole Conjugate with Potent Activity against Microaerophilic and Anaerobic Bacterial Pathogens.
J Med Chem
; 65(6): 4481-4495, 2022 03 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-35175750
19.
Evaluation of ceftazidime and NXL104 in two murine models of infection due to KPC-producing Klebsiella pneumoniae.
Antimicrob Agents Chemother
; 55(1): 82-5, 2011 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-21041503
20.
Discovery of VNRX-7145 (VNRX-5236 Etzadroxil): An Orally Bioavailable ß-Lactamase Inhibitor for Enterobacterales Expressing Ambler Class A, C, and D Enzymes.
J Med Chem
; 64(14): 10155-10166, 2021 07 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-34191513